Company intelligence / Profile preview
GN Corporation
Kofu, Yamanashi, Japangncorporations.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
GN Corporation develops and commercializes regenerative medicine solutions including cell therapies, medical devices, and functional foods. Its autologous immune-cell therapies are used clinically in Japan and have been transferred to hospitals abroad. The company’s proprietary beta-glucans have shown promise as immunomodulators—receiving rare pediatric disease/orphan designations from the US FDA—and are being studied for cancer support, infectious diseases like COVID–19, neuromuscular disorders such as Duchenne muscular dystrophy, and healthy aging. The BEES–HAUS procedure represents an innovative approach to male urethral stricture using tissue engineering.
- Therapeutic areas
- OncologyInfectious DiseasesRare DiseasesMen's Health
- Modalities
- Cell therapy (including autologous immune-cell therapy, NK cell and T-cell therapies)Beta glucan-based biologics/food supplements ("Nichi Glucan", "Neu REFIX")Medical devices for hyperthermia treatment ("Thermotron RF8‑EX")
- Industry
- Biotech
02
Drug pipeline
10 assets9 more assets in the full pipeline.
Request access →03
Partnerships
Edogawa Hospital (Japan) – clinical implementation of BEES–HAUS procedure.Vinmec Hospital (Vietnam) – technology transfer of autologous immune-cell therapies.Sri Ramachandra Institute team/NCRM NICHE – academic collaboration on regenerative medicine competitions/research.
Beyond the preview
Go deeper on GN Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GN Corporation.